BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31759075)

  • 1. Initial Safety and Tumor Control Results From a "First-in-Human" Multicenter Prospective Trial Evaluating a Novel Alpha-Emitting Radionuclide for the Treatment of Locally Advanced Recurrent Squamous Cell Carcinomas of the Skin and Head and Neck.
    Popovtzer A; Rosenfeld E; Mizrachi A; Bellia SR; Ben-Hur R; Feliciani G; Sarnelli A; Arazi L; Deutsch L; Kelson I; Keisari Y
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):571-578. PubMed ID: 31759075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusing alpha-emitters radiation therapy: approximate modeling of the macroscopic alpha particle dose of a point source.
    Arazi L
    Phys Med Biol; 2020 Jan; 65(1):015015. PubMed ID: 31766047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy for Recurrent or Unresectable Skin Cancers.
    D'Andrea MA; VanderWalde NA; Ballo MT; Patra P; Cohen GN; Damato AL; Barker CA
    JAMA Netw Open; 2023 May; 6(5):e2312824. PubMed ID: 37166798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis.
    Lee WR; Mendenhall WM; Parsons JT; Million RR
    Head Neck; 1993; 15(4):320-4. PubMed ID: 8360054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of CT-guided
    Chen Y; Jiang Y; Ji Z; Jiang P; Xu F; Zhang Y; Guo F; Peng R; Li X; Sun H; Lei R; Fan J; Li W; Wang J
    Brachytherapy; 2020; 19(1):81-89. PubMed ID: 31653566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
    Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous computed tomography/ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck.
    Jiang YL; Meng N; Wang JJ; Ran WQ; Yuan HS; Qu A; Yang RJ
    Cancer Biol Ther; 2010 Jun; 9(12):959-66. PubMed ID: 20873398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness and Prognostic Factors of CT-Guided Radioactive I-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer After External Beam Radiation Therapy.
    Ji Z; Jiang Y; Tian S; Guo F; Peng R; Xu F; Sun H; Fan J; Wang J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):638-645. PubMed ID: 30391521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
    Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
    Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
    Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
    Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA
    Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy.
    de Pree C; Popowski Y; Weber D; Nouet P; Rouzaud M; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):971-6. PubMed ID: 10192342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
    Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.